Facial Rhytids

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Facial Rhytids trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT07492277

A Non-Interventional PMCF Study Evaluating Croma Revitalis for the Correction of Fine Lines

This study will serve to collect and analyze additional data on the use of the device croma revitalis for treatment of fine lines on the face including LCL and…

Austria70 participantsStarted 2026-01-16

RecruitingPhase 4

NCT07383766

Aesthetic Improvement of Facial Rhytids Using Injectables

Revanesse® Renew™+ (Prollenium Medical Technologies Inc.) is a non-crosslinked HA skin booster that combines low- and high-molecular-weight HA at a concentratio…

Canada14 participantsStarted 2026-02-25

Treatment: Revanesse® Renew™+

All recent trials (16 shown)

Active — Not RecruitingNot Applicable

NCT06872359

Evaluation of Performance and Safety of Injectable KIO017 Device Range for Facial Tissue Filling

The goal of this clinical trial is to primarily evaluate the performance of KIO017 in filling/volumizing after injection in different areas in healthy women or…

France, Poland210 participantsStarted 2025-03-25

Treatment: KIO017-1, KIO017-2

CompletedNot Applicable

NCT07526870

Intradermal Microbotulinum Toxin for Sebum Reduction and Facial Pore Improvement

This study aims to evaluate the efficacy and safety of microdoses of botulinum toxin type A (microtoxin) for improving periocular skin quality and reducing fine…

Mexico30 participantsStarted 2024-07-24

Treatment: Botulinum Toxin Type A (Dysport®)

Facial Rhytids

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

A Non-Interventional PMCF Study Evaluating Croma Revitalis for the Correction of Fine Lines

Aesthetic Improvement of Facial Rhytids Using Injectables

All recent trials (16 shown)

Evaluation of Performance and Safety of Injectable KIO017 Device Range for Facial Tissue Filling

Intradermal Microbotulinum Toxin for Sebum Reduction and Facial Pore Improvement

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

A Non-Interventional PMCF Study Evaluating Croma Revitalis for the Correction of Fine Lines

Aesthetic Improvement of Facial Rhytids Using Injectables

All recent trials (16 shown)

Evaluation of Performance and Safety of Injectable KIO017 Device Range for Facial Tissue Filling

Intradermal Microbotulinum Toxin for Sebum Reduction and Facial Pore Improvement

Safety and Efficacy of 2910 nm Fiber Laser Resurfacing and Laser-Coring

Performance and Safety of Semical Dermal Fillers in Facial Rejuvenation

RHA® Redensity With New Anesthetic Agent Perioral Rhytids (PAS)

Laser Spot Treatment of Perioral Rhytids

Evaluation of Efficacy and Safety of the triLift™ System

RHA® Redensity With New Anesthetic Agent - Perioral Rhytids

Evaluation of the Ulthera® System for Treatment of the Face and Neck

Botulinum Toxin A Single Blind Split-Face Randomized Pilot Study

Efficacy of Long Pulsed 1064nm Laser for Facial Skin Tightening

Upper Facial Remodeling With Perlane-L and Dysport

Pilot Evaluation of Platelet Rich Fibrin Matrix (PRFM) for the Correction of Nasolabial Folds

Comparative Study of Reconstituted JUVÉDERM® Ultra vs COSMODERM® 1 for Lip and Cheek Lines, Folds or Wrinkles